12-May-2016 - Evotec’s auto-immune spin-out Topas represents “a strategic opportunity” for the CRO, which reported strong first quarter sales this week.
26-Oct-2015 - Science 37 has raised $6.5m (€5.7m) from Lux Capital and dRx Capital, the fund set up by Novartis and Qualcomm, to advance its virtual clinical trial service business.
16-Sep-2015 - Danish biotech Bavarian Nordic has signed a $9m contract from Johnson & Johnson to improve stability of their joint Ebola vaccine. After options and milestone awards, payment could total $33m.
21-Jul-2015 - A new four-year research project involving a consortium of government, non-profit and other large biopharma partners is aiming to create a set of measures that can be used in clinical...
10-Jun-2015 - Site audits by Brazilian pharma regulator ANVISA are “exactly the opposite” to the US FDA’s, says CMO Kemwell as it prepares to export to Brazil for Johnson & Johnson.
15-May-2015 - Experts across the sponsor-CRO spectrum seem to agree on at least one thing: the clinical trial process is ready for a major transformation, though how quickly and what types of...
24-Apr-2015 - Cheaper disposable manufacturing techs and increased demand for outsourced production will see more CMOs enter the contracting sector according to HighTech Business Decisions
17-Mar-2015 - Biogen Idec, GlaxoSmithKline, Johnson & Johnson, Lilly and Pfizer have all committed to investing in the $100m venture capital fund, alongside Alzheimer’s Research UK and the UK government.
05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...
29-Jan-2015 - New hepatitis C drugs produced by Gilead, Janssen and AbbVie contributed to a first quarter spike in revenue for AmeriSourceBergen’s Pharmaceutical Distribution business.
12-Jan-2015 - PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.
23-Dec-2014 - Contract drug developer Evotec AG has achieved multiple milestones resulting in €8m ($9.8m) in revenue thanks to its collaborations with Bayer and Janssen Pharmaceuticals.
15-Dec-2014 - Johnson & Johnson has updated its manufacturing execution software (MES) at an active pharmaceutical ingredient (API) in Belgium.
02-Dec-2014 - Third-party manufacturers anxious about Big Biopharma investments and downbeat industry reports can relax as experts concur “it’s a time of growth for biopharmaceutical outsourcing.”
06-Nov-2014 - BARDA, the US government’s Biomedical Advanced Research and Development Authority, has revealed it sees Ebola “as a bioterrorism threat.”
03-Nov-2014 - In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance...
28-Aug-2014 - Poppies will continue to be the main source of industrial opiates long-term according to GSK, despite a recent breakthrough in efforts to produce it in GM yeast.
28-Jul-2014 - Hikma has bought defunct manufacturer Ben Venue and says it could reactivate the site in the long-term, despite the transfer of equipment across its sterile injectables network.
16-Jul-2014 - Janssen Pharmaceuticals is prepared for Tramadol's reclassification by the US Drug Enforcement Administration (DEA) and says the supply of its versions of the opioid analgesic will not be interrupted.
09-Jun-2014 - J&J says it collaborated with Novartis and GSK to install wind turbines in Cork, Ireland to substantially reduce electricity costs at its local manufacturing plants.
13-Mar-2014 - Australia may lose its status as the leading supplier of pharma grade opium if it does not comply with Big Pharma requests and allow cultivation of the crop on the...
21-Oct-2013 - News from Mylan in Europe and Johnson & Johnson tops this week's in-Pharmatechnologist.com's People on the Move.
04-Oct-2013 - Beleaguered sterile injectables manufacturer Ben Venue Laboratories has announced it will close permanently by the end of 2013 and lay off 1,100 employees in Ohio.
16-Sep-2013 - Johnson & Johnson is battling another onset of quality concerns as its subsidiary Janssen is pulling one lot of its Risperdal Consta injection in the US due to a mold...
02-Sep-2013 - Johnson & Johnson has reorganised its Chinese divisions under one Chairman, and Merck KGaA has a new CIO - welcome to in-Pharmatechnologist's People on the Move.